Search results for: 'developement board iot'

The convergence of IoT and healthcare, known as the internet of medical things (IoMT), is transforming the healthcare landscape, bringing unprecedented connectivity and convenience. However, the rapid proliferation of IoT devices in healthcare exposes critical data security and cybersecurity risks. This Frost & Sullivan study explores data security...

In a highly competitive market with increasing regulatory pressures, Frost & Sullivan has analyzed the current state of the Internet of Medical Things (IoMT) security industry and presents the results of its research in this Frost Radar™, a benchmarking system to spark companies to action according to parameters of growth and innovation. The repo...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...

The rapid expansion of Internet of Things (IoT) ecosystems has intensified the demand for uninterrupted, autonomous sensing solutions that can operate without reliance on conventional batteries. This research study investigates the evolving landscape of self-powered sensors as a foundational technology for next-generation, batteryless IoT—particula...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

Before the introduction of Internet of Things (IoT) technologies in healthcare, patients’ interactions with doctors were often limited to clinic visits, text or tele communications. Due to this doctors were not able to monitor patients’ health continuously and this was affecting the overall treatment outcome. To address this clinical concern, resea...